A phase I study of CD40 agonist monoclonal antibody (CP-870,893) with gemcitabine in pancreatic cancer.

被引：2
|
作者：
Beatty, G. L.
Chiorean, E. G.
Torigian, D. A.
Teitelbaum, U. R.
Sun, W.
Fly, K. D.
Huhn, R. D.
Vonderheide, R. H.
O'Dwyer, P. J.
机构：
[1] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[2] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA
[3] Univ Penn, Philadelphia, PA 19104 USA
[4] Pfizer Inc, New London, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.2539
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2539
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma
    Beatty, Gregory L.
    Torigian, Drew A.
    Chiorean, E. Gabriela
    Saboury, Babak
    Brothers, Alex
    Alavi, Abass
    Troxel, Andrea B.
    Sun, Weijing
    Teitelbaum, Ursina R.
    Vonderheide, Robert H.
    O'Dwyer, Peter J.
    CLINICAL CANCER RESEARCH, 2013, 19 (22) : 6286 - 6295
  • [2] Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody
    Vonderheide, Robert H.
    Flaherty, Keith T.
    Khalil, Magi
    Stumacher, Molly S.
    Bajor, David L.
    Hutnick, Natalie A.
    Sullivan, Patricia
    Mahany, J. Joseph
    Gallagher, Maryann
    Kramer, Amy
    Green, Stephanie J.
    O'Dwyer, Peter J.
    Running, Kelli L.
    Huhn, Richard D.
    Antonia, Scott J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (07) : 876 - 883
  • [3] Phase I study of the CD40 agonist antibody CP-870,893 combined with carboplatin and paclitaxel in patients with advanced solid tumors
    Vonderheide, Robert H.
    Burg, Jennifer M.
    Mick, Rosemarie
    Trosko, Jennifer A.
    Li, Dongguang
    Shaik, M. Naveed
    Tolcher, Anthony W.
    Hamid, Omid
    ONCOIMMUNOLOGY, 2013, 2 (01):
  • [4] Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody.
    Vonderheide, R. H.
    Flaherty, K. T.
    Khalil, M.
    Stumacher, M. S.
    Bajor, D. L.
    Gallagher, M.
    Sullivan, P.
    Mahaney, J. J.
    O'Dwyer, P. J.
    Huhn, R. D.
    Antonia, S. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 101S - 101S
  • [5] Surface expression of CD40 on human melanoma and the direct in vitro growth effects of an anti-CD40 agonist antibody, CP-870,893
    Kalbasi, A.
    Chmielowski, B.
    Ribas, A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 223 - 224
  • [6] Combination of agonistic CD40 monoclonal antibody CP-870,893 and anti-CTLA-4 antibody tremelimumab in patients with metastatic melanoma
    Bajor, David L.
    Mick, Rosemarie
    Riese, Matthew J.
    Richman, Lee P.
    Xu, Xiaowei
    Torigian, Drew A.
    Stelekati, Erietta
    Sweeney, Martha
    Sullivan, Brendan
    Schuchter, Lynn M.
    Amaravadi, Ravi
    Wherry, E. John
    Vonderheide, Robert H.
    CANCER RESEARCH, 2015, 75
  • [7] Phase I study of combination immunotherapy with agonistic CD40 monoclonal antibody (mAb) CP-870,893 (aCD40) and anti-CTLA-4 antibody tremelimumab (treme) in patients with metastatic melanoma
    Bajor, David L.
    Mick, Rosemarie
    Riese, Matthew J.
    Lee, Richman P.
    Xu, Xiaowei
    Torigian, Drew A.
    Stelekati, Erietta
    Sweeney, Martha
    Sullivan, Brendan J.
    Schuchter, Lynn M.
    Amaravadi, Ravi
    Wherry, E. John
    Vonderheide, Robert H.
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)
  • [8] In vivo efficacy of the CD40 agonist antibody CP-870,893 against a broad range of tumor types: Impact of tumor CD40 expression, dendritic cells, and chemotherapy.
    Gladue, R. P.
    Cole, S. H.
    Donovan, C.
    Paradis, T.
    Alpert, R.
    Natoli, E.
    Bedian, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 103S - 103S
  • [9] Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation
    Erica L Carpenter
    Rosemarie Mick
    Jens Rüter
    Robert H Vonderheide
    Journal of Translational Medicine, 7
  • [10] Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation
    Carpenter, Erica L.
    Mick, Rosemarie
    Rueter, Jens
    Vonderheide, Robert H.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2009, 7 : 93
12345